Skip to content
PolarisQB
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us
PolarisQB Logo
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us

Drug Discovery

  • PolarisQB and Syntekabio sign MOU for Collaborative AI and Quantum-powered Drug Development Service
    September 12th, 2023· 2.3 min·
    PolarisQB and Syntekabio sign MOU for Collaborative AI and Quantum-powered Drug Development Service

    PolarisQB, the first company in the world to develop a drug

  • A Very Brief History of Very Large Numbers
    July 17th, 2023· 3.4 min·
    A Very Brief History of Very Large Numbers

    What is the largest number of which you can conceive? This question

  • Work with D-Wave Cited as Changing Drug Discovery and Quantum Computing
    March 17th, 2023· 1.2 min·
    Work with D-Wave Cited as Changing Drug Discovery and Quantum Computing

    Recently, POLARISqb has been in the news for the revolutionary work that

  • Quantum Computing for the Real World: Ars Technica writes about PolarisQB and D-Wave
    January 20th, 2023· 2.9 min·
    Quantum Computing for the Real World: Ars Technica writes about PolarisQB and D-Wave

    Just as the team was returning from some well-deserved time off

  • PolarisQB and PhoreMost announce a Multi-target Collaboration to investigate Next-generation Cancer Therapies
    January 5th, 2022· 1.9 min·
    PolarisQB and PhoreMost announce a Multi-target Collaboration to investigate Next-generation Cancer Therapies

    Polaris Quantum Biotech (POLARISqb), and PhoreMost Limited, a UK-based biopharmaceutical company dedicated

  • March 18th, 2020· 3.2 min·
    WRAL TechWire: Durham quantum-computing startup launches drug discovery platform it says is much faster

    [vc_row][vc_column][vc_column_text]WRAL Techwire DURHAM – Polaris Quantum Biotech (PQB) is coming out of stealth mode to

  • March 16th, 2020· 0.7 min·
    De Novo Digital Drug Design Platform

    [vc_row][vc_column][vc_column_text] A new quantum-inspired platform that brings together pioneering technology from Fujitsu

  • March 16th, 2020· 0.2 min·
    POLARISqb and Fujitsu

    [vc_row][vc_column][vc_column_text] POLARISqb and Fujitsu announces pioneering drug discovery platform to speed up the

Search
Recent Posts
  • An Investigation of Allostery in Epidermal Growth Factor Receptor Using Sextant with Dynamics Simulations to Expand an Apo Site February 28, 2025
  • Combinatorial Optimization vs. Physical Simulation January 19, 2025
  • Quantum-Aided Drug Design for Inhibiting Protein-Protein Interactions for Emerging Threats January 12, 2025
Categories
  • Blog (14)
  • News (43)

Why Quantum

Quantum Computing Today
Quantum vs. Traditional Screening
Quantum vs. AI

QuADD Solutions

Hits & Leads
Joint Development
Pipeline
Platform

Who We Serve

Pharma
Biotech
Agriculture
CROs

Resources

Blog
Whitepapers
Webinars
Publications

Company

About Us
Customers
Partners
News
Team
Contact

212 W Main St
Suite 200 PMB 205
Durham, NC 27701

info@polarisqb.com
919.200.0592

© 2025 All Rights Reserved | Privacy Policy | Terms of Use

Page load link
Go to Top